{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:02:21Z","timestamp":1760140941434,"version":"build-2065373602"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,9]]},"DOI":"10.7759\/cureus.94237","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T23:38:15Z","timestamp":1760053095000},"source":"Crossref","is-referenced-by-count":0,"title":["Kidney Transplantation After Rituximab Treatment for End-Stage Renal Failure With Myeloperoxidase Anti-neutrophil Cytoplasmic and Anti-glomerular Basement Membrane Antibody Positivity: A Case Report"],"prefix":"10.7759","author":[{"given":"Takuya","family":"Sugiura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihito","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiro","family":"Nishibori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaya","family":"Ozeki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayaho","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Furuhashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noritoshi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoki","family":"Kosugi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuta","family":"Sano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shohei","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoichi","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2014.01.024","article-title":"Diagnosis and classification of Goodpasture's disease (anti-GBM)","volume":"48-49","author":"Hellmark T","year":"2014","unstructured":"Hellmark T, Segelmark M. Diagnosis and classification of Goodpasture's disease (anti-GBM). J Autoimmun. 2014, 48-49:108-12. 10.1016\/j.jaut.2014.01.024","journal-title":"J Autoimmun"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1990.72","article-title":"Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis","volume":"37","author":"Jayne DR","year":"1990","unstructured":"Jayne DR, Marshall PD, Jones SJ, Lockwood CM. Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis. Kidney Int. 1990, 37:965-70. 10.1038\/ki.1990.72","journal-title":"Kidney Int"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.03.014","article-title":"Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival,\u00a0frequency of relapse, and outcomes compared to single-seropositive patients","volume":"92","author":"McAdoo SP","year":"2017","unstructured":"McAdoo SP, Tanna A, Hru\u0161kov\u00e1 Z, et al.. Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival,\u00a0frequency of relapse, and outcomes compared to single-seropositive patients. Kidney Int. 2017, 92:693-702. 10.1016\/j.kint.2017.03.014","journal-title":"Kidney Int"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.991469","article-title":"Clinical features and prognosis of MPO-ANCA and anti-GBM double-seropositive patients","volume":"13","author":"Hu X","year":"2022","unstructured":"Hu X, Shen C, Meng T, et al.. Clinical features and prognosis of MPO-ANCA and anti-GBM double-seropositive patients. Front Immunol. 2022, 13:991469. 10.3389\/fimmu.2022.991469","journal-title":"Front Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-134-11-200106050-00009","article-title":"Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression","volume":"134","author":"Levy JB","year":"2001","unstructured":"Levy JB, Turner AN, Rees AJ, Pusey CD. Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med. 2001, 134:1033-42. 10.7326\/0003-4819-134-11-200106050-00009","journal-title":"Ann Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2021.04.011","article-title":"Recurrence and outcome of anti-glomerular basement membrane glomerulonephritis after kidney transplantation","volume":"6","author":"Coche S","year":"2021","unstructured":"Coche S, Sprangers B, Van Laecke S, et al.. Recurrence and outcome of anti-glomerular basement membrane glomerulonephritis after kidney transplantation. Kidney Int Rep. 2021, 6:1888-94. 10.1016\/j.ekir.2021.04.011","journal-title":"Kidney Int Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.14179","article-title":"Long-term outcomes in kidney transplant recipients with end-stage kidney disease due to anti-glomerular basement membrane disease","volume":"35","author":"Singh T","year":"2021","unstructured":"Singh T, Kharadjian TB, Astor BC, Panzer SE. Long-term outcomes in kidney transplant recipients with end-stage kidney disease due to anti-glomerular basement membrane disease. Clin Transplant. 2021, 35:e14179. 10.1111\/ctr.14179","journal-title":"Clin Transplant"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00917.x","article-title":"Clinical features and outcome of patients with both ANCA and anti-GBM antibodies","volume":"66","author":"Levy JB","year":"2004","unstructured":"Levy JB, Hammad T, Coulthart A, Dougan T, Pusey CD. Clinical features and outcome of patients with both ANCA and anti-GBM antibodies. Kidney Int. 2004, 66:1535-40. 10.1111\/j.1523-1755.2004.00917.x","journal-title":"Kidney Int"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/nm.1959","article-title":"Netting neutrophils in autoimmune small-vessel vasculitis","volume":"15","author":"Kessenbrock K","year":"2009","unstructured":"Kessenbrock K, Krumbholz M, Sch\u00f6nermarck U, et al.. Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med. 2009, 15:623-5. 10.1038\/nm.1959","journal-title":"Nat Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2010090928","article-title":"Asymptomatic autoantibodies associate with future anti-glomerular basement membrane disease","volume":"22","author":"Olson SW","year":"2011","unstructured":"Olson SW, Arbogast CB, Baker TP, Owshalimpur D, Oliver DK, Abbott KC, Yuan CM. Asymptomatic autoantibodies associate with future anti-glomerular basement membrane disease. J Am Soc Nephrol. 2011, 22:1946-52. 10.1681\/ASN.2010090928","journal-title":"J Am Soc Nephrol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2019.04.031","article-title":"ANCA-associated vasculitis: core curriculum 2020","volume":"75","author":"Geetha D","year":"2020","unstructured":"Geetha D, Jefferson JA. ANCA-associated vasculitis: core curriculum 2020. Am J Kidney Dis. 2020, 75:124-37. 10.1053\/j.ajkd.2019.04.031","journal-title":"Am J Kidney Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V641178","article-title":"Identification of the alpha 3 chain of type IV collagen as the common autoantigen in antibasement membrane disease and Goodpasture syndrome","volume":"6","author":"Kalluri R","year":"1995","unstructured":"Kalluri R, Wilson CB, Weber M, Gunwar S, Chonko AM, Neilson EG, Hudson BG. Identification of the alpha 3 chain of type IV collagen as the common autoantigen in antibasement membrane disease and Goodpasture syndrome. J Am Soc Nephrol. 1995, 6:1178-85. 10.1681\/ASN.V641178","journal-title":"J Am Soc Nephrol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.ndt.a027889","article-title":"Goodpasture syndrome and end-stage renal failure--to transplant or not to transplant?","volume":"13","author":"Netzer KO","year":"1998","unstructured":"Netzer KO, Merkel F, Weber M. Goodpasture syndrome and end-stage renal failure--to transplant or not to transplant?. Nephrol Dial Transplant. 1998, 13:1346-8. 10.1093\/oxfordjournals.ndt.a027889","journal-title":"Nephrol Dial Transplant"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/417869-kidney-transplantation-after-rituximab-treatment-for-end-stage-renal-failure-with-myeloperoxidase-anti-neutrophil-cytoplasmic-and-anti-glomerular-basement-membrane-antibody-positivity-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T23:38:16Z","timestamp":1760053096000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/417869-kidney-transplantation-after-rituximab-treatment-for-end-stage-renal-failure-with-myeloperoxidase-anti-neutrophil-cytoplasmic-and-anti-glomerular-basement-membrane-antibody-positivity-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.94237","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,9]]}}}